Ganciclovir prophylaxis for cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone

Transplant Proc. 2001 Feb-Mar;33(1-2):1796-8. doi: 10.1016/s0041-1345(00)02684-1.
No abstract available

MeSH terms

  • Adult
  • Antiviral Agents / therapeutic use*
  • Cytomegalovirus Infections / epidemiology
  • Cytomegalovirus Infections / prevention & control*
  • Female
  • Ganciclovir / therapeutic use*
  • Glucocorticoids / therapeutic use
  • Graft Survival
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Incidence
  • Kidney Transplantation* / immunology
  • Kidney Transplantation* / mortality
  • Male
  • Mycophenolic Acid / analogs & derivatives
  • Mycophenolic Acid / therapeutic use
  • Pancreas Transplantation* / immunology
  • Pancreas Transplantation* / mortality
  • Prednisone / therapeutic use
  • Retrospective Studies
  • Survival Rate
  • Tacrolimus / therapeutic use

Substances

  • Antiviral Agents
  • Glucocorticoids
  • Immunosuppressive Agents
  • Mycophenolic Acid
  • Ganciclovir
  • Prednisone
  • Tacrolimus